Larry L Wood is Global President TAVR & Surg of Edwards Lifesciences Corp. Currently has a direct ownership of 223,525 shares of EW, which is worth approximately $14.6 Million. The most recent transaction as insider was on May 11, 2024, when has been sold 985 shares (Common Stock) at a price of $86.72 per share, resulting in proceeds of $85,419. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 224K
0% 3M change
4.55% 12M change
Total Value Held $14.6 Million

Larry L Wood Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 11 2024
SELL
Payment of exercise price or tax liability
$85,419 $86.72 p/Share
985 Reduced 0.44%
223,525 Common Stock
May 07 2024
SELL
Payment of exercise price or tax liability
$59,137 $85.09 p/Share
695 Reduced 0.31%
224,510 Common Stock
May 07 2024
BUY
Grant, award, or other acquisition
-
8,725 Added 3.73%
225,205 Common Stock
May 04 2024
SELL
Payment of exercise price or tax liability
$301,870 $85.25 p/Share
3,541 Reduced 1.61%
216,480 Common Stock
May 04 2024
BUY
Exercise of conversion of derivative security
-
6,675 Added 2.94%
220,021 Common Stock
May 03 2024
SELL
Payment of exercise price or tax liability
$33,598 $85.06 p/Share
395 Reduced 0.18%
213,346 Common Stock
Feb 16 2024
SELL
Payment of exercise price or tax liability
$27,274 $86.04 p/Share
317 Reduced 0.15%
213,476 Common Stock
Dec 13 2023
SELL
Open market or private sale
$622,163 $71.86 p/Share
8,658 Reduced 3.89%
213,793 Common Stock
Dec 13 2023
BUY
Exercise of conversion of derivative security
$392,034 $45.28 p/Share
8,658 Added 3.75%
222,451 Common Stock
Nov 13 2023
SELL
Open market or private sale
$567,316 $65.51 p/Share
8,660 Reduced 3.89%
213,793 Common Stock
Nov 13 2023
BUY
Exercise of conversion of derivative security
$392,124 $45.28 p/Share
8,660 Added 3.75%
222,453 Common Stock
Oct 13 2023
SELL
Open market or private sale
$605,680 $69.94 p/Share
8,660 Reduced 3.89%
213,793 Common Stock
Oct 13 2023
BUY
Exercise of conversion of derivative security
$392,124 $45.28 p/Share
8,660 Added 3.75%
222,453 Common Stock
Sep 14 2023
SELL
Open market or private sale
$637,635 $73.63 p/Share
8,660 Reduced 3.89%
213,793 Common Stock
Sep 14 2023
BUY
Exercise of conversion of derivative security
$392,124 $45.28 p/Share
8,660 Added 3.75%
222,453 Common Stock
Aug 14 2023
SELL
Open market or private sale
$509,185 $79.3 p/Share
6,421 Reduced 2.92%
213,793 Common Stock
Aug 14 2023
BUY
Exercise of conversion of derivative security
$290,742 $45.28 p/Share
6,421 Added 2.83%
220,214 Common Stock
Jul 14 2023
SELL
Open market or private sale
$804,860 $92.94 p/Share
8,660 Reduced 3.89%
213,793 Common Stock
Jul 14 2023
BUY
Exercise of conversion of derivative security
$392,124 $45.28 p/Share
8,660 Added 3.75%
222,453 Common Stock
Jun 14 2023
SELL
Open market or private sale
$781,911 $90.29 p/Share
8,660 Reduced 3.89%
213,793 Common Stock
Jun 14 2023
BUY
Exercise of conversion of derivative security
$392,124 $45.28 p/Share
8,660 Added 3.75%
222,453 Common Stock
May 24 2023
SELL
Open market or private sale
$540,840 $84.23 p/Share
6,421 Reduced 2.92%
213,793 Common Stock
May 24 2023
BUY
Exercise of conversion of derivative security
$290,742 $45.28 p/Share
6,421 Added 2.83%
220,214 Common Stock
May 11 2023
BUY
Grant, award, or other acquisition
-
7,775 Added 3.51%
213,793 Common Stock
May 08 2023
SELL
Payment of exercise price or tax liability
$130,625 $88.74 p/Share
1,472 Reduced 0.71%
206,310 Common Stock

Also insider at

PRCT
PROCEPT BioRobotics Corp Healthcare
LLW

Larry L Wood

Global President TAVR & Surg
Irvine, CA

Track Institutional and Insider Activities on EW

Follow Edwards Lifesciences Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW